| |
| |
|
| Insider
Information: |
Singer Jack W |
| Relationship: |
EVP, Chief Scientific ... |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
994,057 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$9,035,978 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
994,057 |
|
|
| Total
Value |
$9,035,978 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cti Biopharma Corporation |
CTIC |
EVP, Chief Scientific ... |
2016-03-21 |
994,057 |
2003-12-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Scientific Officer |
• • – |
2016-03-21 |
4 |
D |
$0.55 |
$25,182 |
D/D |
(45,935) |
994,057 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Scientific Officer |
• • – |
2016-02-26 |
4 |
AS |
$0.62 |
$9,517 |
D/D |
(15,000) |
1,039,992 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Scientific Officer |
• • – |
2016-01-29 |
4 |
AS |
$1.17 |
$17,730 |
D/D |
(15,000) |
1,054,992 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Chief Scientific Officer |
• • – |
2015-12-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(236,858) |
1,069,992 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP Global Medical Affairs |
• • – |
2015-12-18 |
4 |
AS |
$1.17 |
$17,673 |
D/D |
(15,000) |
1,306,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-11-27 |
4 |
AS |
$1.20 |
$18,157 |
D/D |
(15,000) |
1,321,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-10-23 |
4 |
AS |
$1.61 |
$24,335 |
D/D |
(15,000) |
1,336,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• – – |
2015-09-30 |
4 |
S |
$1.45 |
$36,443 |
D/D |
(25,000) |
1,351,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• – – |
2015-09-29 |
4 |
S |
$1.38 |
$105,348 |
D/D |
(75,000) |
1,376,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-09-25 |
4 |
AS |
$1.63 |
$24,584 |
D/D |
(15,000) |
1,451,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
205,931 |
1,466,850 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-08-28 |
4 |
AS |
$1.55 |
$23,718 |
D/D |
(15,000) |
1,260,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-07-24 |
4 |
S |
$1.88 |
$28,664 |
D/D |
(15,000) |
1,275,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-06-26 |
4 |
AS |
$2.04 |
$31,024 |
D/D |
(15,000) |
1,290,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-05-22 |
4 |
AS |
$1.73 |
$26,045 |
D/D |
(15,000) |
1,305,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-04-24 |
4 |
AS |
$1.94 |
$29,443 |
D/D |
(15,000) |
1,320,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-03-21 |
4 |
D |
$1.94 |
$181,832 |
D/D |
(93,970) |
1,335,919 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-03-20 |
4 |
AS |
$1.92 |
$131,125 |
D/D |
(67,600) |
1,429,889 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP Global Medical Affairs |
• • – |
2015-02-27 |
4 |
AS |
$2.35 |
$35,251 |
D/D |
(15,000) |
1,497,489 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2015-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
477,255 |
1,512,489 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2014-03-24 |
4 |
S |
$3.46 |
$208,315 |
D/D |
(60,000) |
1,035,234 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
See Remarks |
• • – |
2014-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
394,199 |
1,095,234 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2013-06-05 |
4 |
S |
$1.26 |
$12,600 |
D/D |
(10,000) |
701,035 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
296,705 |
711,035 |
0 |
- |
|
| CTIC |
Cti Biopharma Corporation |
EVP, Global Medical Affairs |
• • – |
2013-03-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(68,174) |
414,330 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
